Showing 1 - 20 results of 35 for search 'Development Research Center of the State Council', query time: 0.11s Refine Results
  1. 1

    Professional propaedeutic council in the university by N. N. Malyarchuk, G. M. Krinitzyna, E. V. Pashchenko, V. V. Pivnenko

    Published 2019-04-01
    “…However, one of the obstacles to IE is the lack of readiness for new requirements and inclusive activity of a vast majority of teachers. When developing and implementing adapted vocational education programmes (AVEP) for students with disabilities, the teachers need regular consultations and specialists’ qualified assistance in the sphere of medicine, defectology, pedagogical and correctional psychology.The aim of the present publication was to justify the rationale for creating a professional propaedeutic council (PPC) at a higher educational institution as a permanent system to manage and support the process of vocational education for people with disabilities.Methodology and research methods. …”
    Get full text
    Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Contextual Vulnerability Should Guide Fair Subject Selection in Xenotransplantation Clinical Trials by Gianna Strand

    Published 2023-03-01
    “…“Exploitation and the Enterprise of Medical Research,” in Exploitation and Developing Countries, ed. …”
    Get full text
    Article
  10. 10
  11. 11

    Novel type 2 diabetes prediction score based on traditional risk factors and circulating metabolites: model derivation and validation in two large cohort studiesResearch in context by Ruijie Xie, Christian Herder, Sha Sha, Lei Peng, Hermann Brenner, Ben Schöttker

    Published 2025-01-01
    “…The German Diabetes Center is funded by the German Federal Ministry of Health (Berlin, Germany) and the Ministry of Culture and Science of the state North Rhine-Westphalia (Düsseldorf, Germany) and receives additional funding from the German Federal Ministry of Education and Research (BMBF) through the German Center for Diabetes Research (DZD e.V.).…”
    Get full text
    Article
  12. 12
  13. 13

    Should the Food and Drug Administration Limit Placebo-Controlled Trials? by Max Goodman, Connor Pedersen

    Published 2022-07-01
    “…The International Ethical Guidelines for Biomedical Research Involving Human Subjects permits PCTs if the consequences are negligible, when methodologically advantageous, and when responses have been historically erratic.[8] The Council for International Organization of Medical Science’s guidelines for biomedical research involving human subjects echoed the Declaration of Helsinki in guideline 11, stating that a “‘placebo may be used: When there is no effective intervention; when withholding an established, effective intervention would expose to, at most temporary discomfort, or delay in relief symptoms; when use of an established, effective intervention as comparator would not yield scientifically reliable results and the use of the placebo would not add risk of serious or irreversible harm to subjects.”[9] The Belmont Report notes three ethical principles: beneficence, respect for persons (autonomy), and justice. …”
    Get full text
    Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20